Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             154 results found
no title author magazine year volume issue page(s) type
1 α1-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties Hochepied, Tino
2003
71-72 1 p. 25-34
10 p.
article
2 Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL Sattler, Martin
1997
71-72 1 p. 63-79
17 p.
article
3 Adiponectin: A biomarker for rheumatoid arthritis? Chen, Xiuping
2013
71-72 1 p. 83-89
7 p.
article
4 Alternate signalling pathways from the interleukin-2 receptor Ellery, Jonathan M.
2002
71-72 1 p. 27-40
14 p.
article
5 A new partner for inhibitory Smads Miyazono, Kohei
2002
71-72 1 p. 7-9
3 p.
article
6 An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17 Grine, Lynda
2015
71-72 1 p. 25-33
9 p.
article
7 Announcement 1996
71-72 1 p. 113-
1 p.
article
8 An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders Yang, Yang
2015
71-72 1 p. 47-57
11 p.
article
9 Antiviral defense: RIG-Ing the immune system to STING Bowzard, J. Bradford
2009
71-72 1 p. 1-5
5 p.
article
10 Bone morphogenetic proteins: An unconventional approach to isolation of first mammalian morphogens Reddi, A Hari
1997
71-72 1 p. 11-20
10 p.
article
11 Book review 1998
71-72 1 p. 89-90
2 p.
article
12 Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor gp130 dependent pathways Pennica, Diane
1996
71-72 1 p. 81-91
11 p.
article
13 CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis Zhang, Jian
2010
71-72 1 p. 41-48
8 p.
article
14 CD100/Sema4D, a lymphocyte semaphorin involved in the regulation of humoral and cellular immune responses Suzuki, Kazuhiro
2003
71-72 1 p. 17-24
8 p.
article
15 Characterization and potential clinical applications of autoantibodies against cytokines de Lemos Rieper, Carina
2009
71-72 1 p. 61-75
15 p.
article
16 Chemokine receptors: Structure, function and role in microbial pathogenesis Murphy, Philip M
1996
71-72 1 p. 47-64
18 p.
article
17 Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12 Singh, Anup Kumar
2013
71-72 1 p. 41-49
9 p.
article
18 Chemokines in immune-mediated inflammation of the central nervous system Ransohoff, Richard M
1996
71-72 1 p. 35-46
12 p.
article
19 conference calendar 2003
71-72 1 p. 83-
1 p.
article
20 Conference calendar 1996
71-72 1 p. 119-120
2 p.
article
21 Conference calendar 1997
71-72 1 p. 99-100
2 p.
article
22 Conference calendar 2005
71-72 1 p. V-VI
nvt p.
article
23 Conference calendar 2004
71-72 1 p. 81-82
2 p.
article
24 Conference Calender 2002
71-72 1 p. 91-
1 p.
article
25 Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands Horowitz, Mark C
2001
71-72 1 p. 9-18
10 p.
article
26 Corrigendum to “The tale of soluble receptors and binding proteins: From bench to bedside” [Cytokine Growth Factor Rev. 18 (2007) 525–33] Novick, Daniela
2008
71-72 1 p. 109-
1 p.
article
27 CXCR3, CXCL10 and type 1 diabetes Antonelli, Alessandro
2014
71-72 1 p. 57-65
9 p.
article
28 Cytokine and cytokine receptor gene polymorphisms and their functionality Smith, Andrew J.P.
2009
71-72 1 p. 43-59
17 p.
article
29 Cytokine and Growth Factor Reviews to be published six times a year Sporn, Michael
2002
71-72 1 p. 1-2
2 p.
article
30 Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis Avau, Anneleen
2015
71-72 1 p. 35-45
11 p.
article
31 Cytokine regulation of cellular adhesion molecule expression in inflammation Meager, A.
1999
71-72 1 p. 27-39
13 p.
article
32 Cytokines, dendritic cells and immunological rejection Ferrantini, Maria
2008
71-72 1 p. 1-2
2 p.
article
33 Cytokines in 1995 Vilĉek, Jan T.
1996
71-72 1 p. 103-106
4 p.
article
34 Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer Grivennikov, Sergei I.
2010
71-72 1 p. 11-19
9 p.
article
35 Dendritic cells and cytokines in human inflammatory and autoimmune diseases Blanco, Patrick
2008
71-72 1 p. 41-52
12 p.
article
36 Dendritic cells and cytokines in immune rejection of cancer Ferrantini, Maria
2008
71-72 1 p. 93-107
15 p.
article
37 Dendritic cells and innate defense against tumor cells Ullrich, Evelyn
2008
71-72 1 p. 79-92
14 p.
article
38 Discussion 1998
71-72 1 p. 85-87
3 p.
article
39 Distinctive features of Trk neurotrophin receptor transactivation by G protein-coupled receptors Lee, Francis S.
2002
71-72 1 p. 11-17
7 p.
article
40 Does cytokine signaling link sphingolipid metabolism to host defense and immunity against virus infections? Seo, Young-Jin
2011
71-72 1 p. 55-61
7 p.
article
41 Dominance of the strongest: Inflammatory cytokines versus glucocorticoids Dejager, Lien
2014
71-72 1 p. 21-33
13 p.
article
42 Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor Nanba, Daisuke
2004
71-72 1 p. 13-19
7 p.
article
43 Dual role for TGF-β1 in apoptosis Sánchez-Capelo, Amelia
2005
71-72 1 p. 15-34
20 p.
article
44 Editorial Board 2009
71-72 1 p. CO2-
1 p.
article
45 Editorial Board 2010
71-72 1 p. CO2-
1 p.
article
46 Editorial Board 1996
71-72 1 p. IFC-
1 p.
article
47 Editorial Board 1997
71-72 1 p. IFC-
1 p.
article
48 Editorial Board 2008
71-72 1 p. CO2-
1 p.
article
49 Editorial Board 2011
71-72 1 p. CO2-
1 p.
article
50 Editorial Board 2013
71-72 1 p. CO2-
1 p.
article
51 Editorial Board and Publication information 2014
71-72 1 p. CO2-
1 p.
article
52 Editorial Board and Publication information 2015
71-72 1 p. IFC-
1 p.
article
53 Editorial Board/Publication info 2003
71-72 1 p. IFC-
1 p.
article
54 Editorial Board/Publication info. 2005
71-72 1 p. CO2-
1 p.
article
55 Editorial Board/Publication info. 2004
71-72 1 p. IFC-
1 p.
article
56 Emerging role of interleukin-22 in autoimmune diseases Pan, Hai-Feng
2013
71-72 1 p. 51-57
7 p.
article
57 Eph receptor tyrosine kinases in cancer stem cells Chen, Jin
2015
71-72 1 p. 1-6
6 p.
article
58 Expression profiling in knockout mice: lymphotoxin versus tumor necrosis factor in the maintenance of splenic microarchitecture Shakhov, Alexander N
2001
71-72 1 p. 107-119
13 p.
article
59 Extracellular regulation of VEGF: Isoforms, proteolysis, and vascular patterning Vempati, Prakash
2014
71-72 1 p. 1-19
19 p.
article
60 Facts and Faces 2002
71-72 1 p. 87-89
3 p.
article
61 Facts and faces 2001
71-72 1 p. 127-
1 p.
article
62 Facts and faces 2001
71-72 1 p. 121-125
5 p.
article
63 Facts and faces 1996
71-72 1 p. 115-118
4 p.
article
64 Facts and faces 1997
71-72 1 p. 97-
1 p.
article
65 FLT3: Receptor and Ligand. Biology and Potential Clinical Application Shurin, Michael R
1998
71-72 1 p. 37-48
12 p.
article
66 Foreword Balkwill, Frances
2010
71-72 1 p. 1-
1 p.
article
67 Genetic and biochemical analysis of TGFβ signal transduction Padgett, Richard W
1997
71-72 1 p. 1-9
9 p.
article
68 Heart-specific expression of FGF-16 and a potential role in postnatal cardioprotection Wang, Jie
2015
71-72 1 p. 59-66
8 p.
article
69 Hematopoietic growth factor mimetics: From concept to clinic Perugini, Michelle
2009
71-72 1 p. 87-94
8 p.
article
70 IFN regulation and functions in myeloid dendritic cells Coccia, Eliana Marina
2008
71-72 1 p. 21-32
12 p.
article
71 IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology Steeve, Kwan Tat
2004
71-72 1 p. 49-60
12 p.
article
72 Index 1999
71-72 1 p. VII-
1 p.
article
73 Index 1999
71-72 1 p. V-
1 p.
article
74 Inducible nitric oxide synthase activation by interleukin-17 Miljkovic, Djordje
2004
71-72 1 p. 21-32
12 p.
article
75 Infection and cancer: the common vein Thomas-Tikhonenko, Andrei
2003
71-72 1 p. 67-77
11 p.
article
76 Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation Mohty, Mohamad
2008
71-72 1 p. 53-63
11 p.
article
77 Insulin-like growth factor binding proteins and their role in controlling IGF actions Clemmons, David R
1997
71-72 1 p. 45-62
18 p.
article
78 Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation Heemskerk, Vincent H
1999
71-72 1 p. 5-14
10 p.
article
79 Interferon-γ in autoimmunity Billiau, Alfons
1996
71-72 1 p. 25-34
10 p.
article
80 Interferons and cytokines on a grand scale Balkwill, Fran
1997
71-72 1 p. 91-95
5 p.
article
81 Interferons in 1995 Pfeffer, Lawrence M.
1996
71-72 1 p. 107-111
5 p.
article
82 Interleukin 5 and B cell differentiation Takatsu, Kiyoshi
1998
71-72 1 p. 25-35
11 p.
article
83 Interleukin-6 and prostate cancer progression Smith, Peter C
2001
71-72 1 p. 33-40
8 p.
article
84 Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions Mukaida, Naofumi
1998
71-72 1 p. 9-23
15 p.
article
85 Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal homeostasis Giron-Michel, Julien
2013
71-72 1 p. 13-22
10 p.
article
86 Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu Nakanishi, Kenji
2001
71-72 1 p. 53-72
20 p.
article
87 Interleukin-15: New kid on the block for antitumor combination therapy Van den Bergh, Johan M.J.
2015
71-72 1 p. 15-24
10 p.
article
88 Interleukin-7: physiological roles and mechanisms of action Hofmeister, R.
1999
71-72 1 p. 41-60
20 p.
article
89 ISGF3γ p48, a specificity switch for interferon activated transcription factors Bluyssen, Hans A.R.
1996
71-72 1 p. 11-17
7 p.
article
90 Kaposi’s sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents Ensoli, Barbara
1998
71-72 1 p. 63-83
21 p.
article
91 Ligand-induced dimerization of growth factor receptors: Variations on the theme Heldin, Carl-Henrik
1996
71-72 1 p. 3-10
8 p.
article
92 Lymphocytes in cancer development: Polarization towards pro-tumor immunity Ruffell, Brian
2010
71-72 1 p. 3-10
8 p.
article
93 Matricellular proteins and inflammatory cells: A task force to promote or defeat cancer? Llera, Andrea Sabina
2010
71-72 1 p. 67-76
10 p.
article
94 MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine Sauane, Moira
2003
71-72 1 p. 35-51
17 p.
article
95 Mechanism of BLyS action in B cell immunity Do, Richard Kinh Gian
2002
71-72 1 p. 19-25
7 p.
article
96 MIF, CD74 and other partners in kidney disease: Tales of a promiscuous couple Sanchez-Niño, M.D.
2013
71-72 1 p. 23-40
18 p.
article
97 MIF re-discovered: Pituitary hormone and glucocorticoid-induced regulator of cytokine production Bucala, Richard
1996
71-72 1 p. 19-24
6 p.
article
98 Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis Marchesi, Federica
2010
71-72 1 p. 77-82
6 p.
article
99 MSP: An emerging player in metabolic syndrome Li, Jieyi
2015
71-72 1 p. 75-82
8 p.
article
100 Negative regulation of RelA phosphorylation: Emerging players and their roles in cancer Lu, Xinyuan
2015
71-72 1 p. 7-13
7 p.
article
101 Neurotrophic factors: effects in modulating properties of the neuromuscular endplate Sendtner, Michael
1998
71-72 1 p. 1-7
7 p.
article
102 New perspectives on growth factor-sex steroid interaction in the prostate Ball, Emma M.A
2003
71-72 1 p. 5-16
12 p.
article
103 NF-κB and cell-cycle regulation: the cyclin connection Joyce, David
2001
71-72 1 p. 73-90
18 p.
article
104 NF-κB modulators in osteolytic bone diseases Xu, Jiake
2009
71-72 1 p. 7-17
11 p.
article
105 Non-apoptotic Fas signaling Wajant, Harald
2003
71-72 1 p. 53-66
14 p.
article
106 Pathways mediating VEGF-independent tumor angiogenesis Ferrara, Napoleone
2010
71-72 1 p. 21-26
6 p.
article
107 Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history Fitzgerald-Bocarsly, Patricia
2008
71-72 1 p. 3-19
17 p.
article
108 Pleiotropic roles of formyl peptide receptors Le, Yingying
2001
71-72 1 p. 91-105
15 p.
article
109 Proteases and bone remodelling Georges, S.
2009
71-72 1 p. 29-41
13 p.
article
110 Regulation of hepatocyte fate by interferon-γ Horras, Christopher J.
2011
71-72 1 p. 35-43
9 p.
article
111 Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2) Charrier, Alyssa
2013
71-72 1 p. 59-68
10 p.
article
112 REMOVED: The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction Schlegel, Amnon
2001
71-72 1 p. 41-51
11 p.
article
113 Role of adiponectin in obesity related gastrointestinal carcinogenesis Nagaraju, Ganji Purnachandra
2015
71-72 1 p. 83-93
11 p.
article
114 Role of calprotectin in cardiometabolic diseases Kruzliak, Peter
2014
71-72 1 p. 67-75
9 p.
article
115 Role of IL-15 in immune-mediated and infectious diseases Di Sabatino, Antonio
2011
71-72 1 p. 19-33
15 p.
article
116 Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition Maulik, Gautam
2002
71-72 1 p. 41-59
19 p.
article
117 Scatter Factors in renal disease: Dr. Jeckyll and Mr. Hyde? Rampino, Teresa
2009
71-72 1 p. 77-85
9 p.
article
118 Signal transduction by bone morphogenetic proteins Kawabata, Masahiro
1998
71-72 1 p. 49-61
13 p.
article
119 Ski/Sno and TGF-β signaling Liu, Xuedong
2001
71-72 1 p. 1-8
8 p.
article
120 Soluble interleukin-1 receptor — reverse signaling in innate immunoregulation Spörri, Bernhard
2001
71-72 1 p. 27-32
6 p.
article
121 Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family Geijsen, Niels
2001
71-72 1 p. 19-25
7 p.
article
122 Sphingosine 1-phosphate, a key mediator of the cytokine network: Juxtacrine signaling Xia, Pu
2011
71-72 1 p. 45-53
9 p.
article
123 Tempting fate: BMP signals for cardiac morphogenesis Schneider, Michael D
2003
71-72 1 p. 1-4
4 p.
article
124 The “bone morphogenic proteins” pathways in bone and joint diseases: Translational perspectives from physiopathology to therapeutic targets Biver, Emmanuel
2013
71-72 1 p. 69-81
13 p.
article
125 The chemokine system in cancer biology and therapy Mantovani, Alberto
2010
71-72 1 p. 27-39
13 p.
article
126 The Class II cytokine receptor (CRF2) family: overview and patterns of receptor–ligand interactions Langer, Jerome A
2004
71-72 1 p. 33-48
16 p.
article
127 The dual role of IL-6-type cytokines on bone remodeling and bone tumors Blanchard, Frédéric
2009
71-72 1 p. 19-28
10 p.
article
128 The ephrins and Eph receptors in angiogenesis Cheng, Nikki
2002
71-72 1 p. 75-85
11 p.
article
129 The ever-increasing complexity of TGF-β signaling Roberts, Anita B.
2002
71-72 1 p. 3-5
3 p.
article
130 The house that JAK/STAT built Levy, David E
1997
71-72 1 p. 81-90
10 p.
article
131 The inauguration of cytokine & growth factor reviews Sporn, Michael B.
1996
71-72 1 p. 1-
1 p.
article
132 The MCP/eotaxin subfamily of CC chemokines Van Coillie, Els
1999
71-72 1 p. 61-86
26 p.
article
133 The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle Mocellin, Simone
2004
71-72 1 p. 61-76
16 p.
article
134 The resolution of inflammation and cancer Rodriguez-Vita, Juan
2010
71-72 1 p. 61-65
5 p.
article
135 The role of “anti-inflammatory” cytokines in axon regeneration Vidal, Pía M.
2013
71-72 1 p. 1-12
12 p.
article
136 The role of SATB2 in skeletogenesis and human disease Zhao, Xiaoying
2014
71-72 1 p. 35-44
10 p.
article
137 The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer Vandercappellen, Jo
2011
71-72 1 p. 1-18
18 p.
article
138 The role of transforming growth factor (TGF)-β in modulating the immune response and fibrogenesis in the gut Biancheri, Paolo
2014
71-72 1 p. 45-55
11 p.
article
139 The roles and potential therapeutic implications of CXCL4 and its variant CXCL4L1 in the pathogenesis of chronic liver allograft dysfunction Li, Jing
2015
71-72 1 p. 67-74
8 p.
article
140 The transforming growth factor-β superfamily of receptors de Caestecker, Mark
2004
71-72 1 p. 1-11
11 p.
article
141 Thrombopoietin: a pan-hematopoietic cytokine Geddis, Amy E
2002
71-72 1 p. 61-73
13 p.
article
142 TNF receptor associated factors in cytokine signaling Wajant, H
1999
71-72 1 p. 15-26
12 p.
article
143 Transcriptional regulation of vascular endothelial growth factor in cancer Loureiro, Robyn M.B.
2005
71-72 1 p. 77-89
13 p.
article
144 Transcriptional signaling by double-stranded RNA: role of TLR3 Sen, Ganes C.
2005
71-72 1 p. 1-14
14 p.
article
145 Transforming growth factor beta (TGF-β) and inflammation in cancer Bierie, Brian
2010
71-72 1 p. 49-59
11 p.
article
146 Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity Pepper, Michael S
1997
71-72 1 p. 21-43
23 p.
article
147 Tumor-induced modulation of dendritic cell function Gottfried, Eva
2008
71-72 1 p. 65-77
13 p.
article
148 Tumor necrosis factor, cancer and anticancer therapy Mocellin, Simone
2005
71-72 1 p. 35-53
19 p.
article
149 Tumor suppressor activity of the TGF-β pathway in human cancers Markowitz, Sanford D
1996
71-72 1 p. 93-102
10 p.
article
150 Tumor therapeutics by design: targeting and activation of death receptors Wajant, Harald
2005
71-72 1 p. 55-76
22 p.
article
151 Type I interferon as a stimulus for cross-priming Le Bon, Agnès
2008
71-72 1 p. 33-40
8 p.
article
152 Up and down the growth hormone cascade Clark, Ross G
1996
71-72 1 p. 65-80
16 p.
article
153 Viral chemokine-modulatory proteins: tools and targets Boomker, Jasper M.
2005
71-72 1 p. 91-103
13 p.
article
154 Virus-encoded modulators of cytokines and growth factors Spriggs, Melanie K
1999
71-72 1 p. 1-4
4 p.
article
                             154 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands